Clearline Capital LP Bausch Health Companies Inc. Transaction History

Clearline Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $6.02 Million - $10.3 Million	987,206 New	987,206 $6.88 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $1.48 Million - $2.28 Million	258,876 Added 28.5%	1,167,343 $9.34 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $48,356 - $75,845	-7,700 Reduced 0.84%	908,467 $7.36 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $303,915 - $395,738	49,904 Added 5.76%	916,167 $5.75 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $3.02 Million - $6.07 Million	-659,100 Reduced 43.21%	866,263 $5.97 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $10.8 Million - $36 Million	1,525,363 New	1,525,363 $12.8 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $772,986 - $1.07 Million	-50,489 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $3.6 Million - $4.88 Million	-242,211 Reduced 82.75%	50,489 $785,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $3.9 Million - $6 Million	292,700 New	292,700 $5.35 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.